These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 36525304)
1. The Prognostic and Predictive Effects of Human Papillomavirus Status in Hypopharyngeal Carcinoma: Population-Based Study. Yang SP; Lin XY; Hu M; Cai CF JMIR Public Health Surveill; 2022 Dec; 8(12):e40185. PubMed ID: 36525304 [TBL] [Abstract][Full Text] [Related]
2. The effect of human papillomavirus status on prognosis and local treatment strategies of T1-2N0 oropharyngeal squamous cell cancer. Zhou P; Chen DL; Lian CL; Wu SG; Zhang SY Front Public Health; 2022; 10():900294. PubMed ID: 35958856 [TBL] [Abstract][Full Text] [Related]
3. Impact of cisplatin dose intensity on human papillomavirus-related and -unrelated locally advanced head and neck squamous cell carcinoma. Spreafico A; Huang SH; Xu W; Granata R; Liu CS; Waldron JN; Chen E; Ringash J; Bayley A; Chan KK; Hope AJ; Cho J; Razak AA; Hansen A; Jang R; Perez-Ordonez B; Weinreb I; Bossi P; Orlandi E; Licitra LF; Song Y; O'Sullivan B; Siu LL; Kim J Eur J Cancer; 2016 Nov; 67():174-182. PubMed ID: 27669504 [TBL] [Abstract][Full Text] [Related]
4. A novel prognostic model predicting the long-term cancer-specific survival for patients with hypopharyngeal squamous cell carcinoma. Tang X; Pang T; Yan WF; Qian WL; Gong YL; Yang ZG BMC Cancer; 2020 Nov; 20(1):1095. PubMed ID: 33176731 [TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus-associated squamous cell carcinoma of the larynx or hypopharynx: Clinical outcomes and implications for laryngeal preservation. Hughes RT; Beuerlein WJ; O'Neill SS; Porosnicu M; Lycan TW; Waltonen JD; Frizzell BA; Greven KM Oral Oncol; 2019 Nov; 98():20-27. PubMed ID: 31536842 [TBL] [Abstract][Full Text] [Related]
6. Prognostic value of HPV status among patients with hypopharyngeal carcinoma: a population-based study. Abdel-Rahman O Clin Transl Oncol; 2020 Sep; 22(9):1645-1650. PubMed ID: 31939101 [TBL] [Abstract][Full Text] [Related]
7. Survival outcomes by high-risk human papillomavirus status in nonoropharyngeal head and neck squamous cell carcinomas: A propensity-scored analysis of the National Cancer Data Base. Tian S; Switchenko JM; Jhaveri J; Cassidy RJ; Ferris MJ; Press RH; Pfister NT; Patel MR; Saba NF; McDonald MW; Higgins KA; Yu DS; Curran WJ; Gillespie TW; Beitler JJ Cancer; 2019 Aug; 125(16):2782-2793. PubMed ID: 31012957 [TBL] [Abstract][Full Text] [Related]
8. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site. Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864 [TBL] [Abstract][Full Text] [Related]
9. The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma. An Y; Park HS; Kelly JR; Stahl JM; Yarbrough WG; Burtness BA; Contessa JN; Decker RH; Koshy M; Husain ZA Cancer; 2017 Jul; 123(14):2762-2772. PubMed ID: 28323338 [TBL] [Abstract][Full Text] [Related]
10. Survival Outcomes and Treatment Decision by Human Papillomavirus Status Among Patients With Stage IVC Head and Neck Squamous Cell Carcinoma. Zhou P; Yu YF; Lian CL; Wang J; Zhuo RG; Wu SG Front Oncol; 2021; 11():668066. PubMed ID: 34136400 [TBL] [Abstract][Full Text] [Related]
11. Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial. Fakhry C; Westra WH; Li S; Cmelak A; Ridge JA; Pinto H; Forastiere A; Gillison ML J Natl Cancer Inst; 2008 Feb; 100(4):261-9. PubMed ID: 18270337 [TBL] [Abstract][Full Text] [Related]
12. Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer. Baliga S; Mitchell D; Yildiz VO; Gogineni E; Konieczkowski DJ; Grecula J; Blakaj DM; Liu X; Gamez ME J Med Virol; 2023 Feb; 95(2):e28448. PubMed ID: 36583477 [TBL] [Abstract][Full Text] [Related]
13. Early-stage hypopharyngeal squamous cell carcinoma treated with radical radiotherapy at a uniform dose of 70 Gy in 35 fractions: a single-center study. Katano A; Yamashita H Eur Arch Otorhinolaryngol; 2024 Aug; 281(8):4401-4407. PubMed ID: 38719981 [TBL] [Abstract][Full Text] [Related]
14. Oncological outcomes from surgical vs. non-surgical treatments for advanced hypopharyngeal squamous cell carcinoma: a surveillance, epidemiology, and end results-based study. Fan Y; Li S; Xia X; Yu S; Zhu X; Zhu Y; Diao W; Chen X Clin Transl Oncol; 2022 Dec; 24(12):2379-2387. PubMed ID: 35882729 [TBL] [Abstract][Full Text] [Related]
16. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Fakhry C; Westra WH; Wang SJ; van Zante A; Zhang Y; Rettig E; Yin LX; Ryan WR; Ha PK; Wentz A; Koch W; Richmon JD; Eisele DW; D'Souza G Cancer; 2017 May; 123(9):1566-1575. PubMed ID: 28241096 [TBL] [Abstract][Full Text] [Related]
17. Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment. Salazar CR; Smith RV; Garg MK; Haigentz M; Schiff BA; Kawachi N; Anayannis N; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF Head Neck Pathol; 2014 Mar; 8(1):77-87. PubMed ID: 24002971 [TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer. Burbure N; Handorf E; Ridge JA; Bauman J; Liu JC; Giri A; Galloway TJ Head Neck; 2021 Oct; 43(10):3042-3052. PubMed ID: 34165223 [TBL] [Abstract][Full Text] [Related]
19. Low expression of AIM2 combined with high expression of p‑STAT3 is associated with poor prognosis in hypopharyngeal squamous cell carcinoma. Li Z; Shi X; Li H; Wang W; Li X Oncol Rep; 2019 Apr; 41(4):2396-2408. PubMed ID: 30816544 [TBL] [Abstract][Full Text] [Related]
20. The role of concomitant chemoradiotherapy versus radiation alone in T1-3N0 HPV-positive and HPV-negative oropharyngeal squamous cell carcinoma. Shiao JC; Holt D; Ladbury C; Gao D; Jones B; Karam SD; Amini A Oral Oncol; 2022 Jul; 130():105907. PubMed ID: 35605559 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]